EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gasdermin D Inhibitor Necrosulfonamide Alleviates Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice

Jia Guo, Qing Zhang, Zhidong Li, Min Qin, Jinyun Shi, Yan Wang, Wenjia Ai iD, Junjie Ju, Makoto Samura, Philip S Tsao, Baohui Xu iD

Biomolecules · 2024

DOI: 10.3390/biom14060726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Jia Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, First Hospital Shanxi Medical University, Taiyuan 030001, Shanxi, China. Hauptthemen laut MEDLINE: Angiotensin II, Aortic Aneurysm, Abdominal, Sulfonamides, Apolipoproteins E. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Abroad Return Scholar Fund of Shanxi Province, Central Funds Guiding the Local Science and Technology Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abdominal aortic aneurysm (AAA) is a chronic aortic disease that lacks effective pharmacological therapies. This study was performed to determine the influence of treatment with the gasdermin D inhibitor necrosulfonamide on experimental AAAs. AAAs were induced in male apolipoprotein E-deficient mice by subcutaneous angiotensin II infusion (1000 ng/kg body weight/min), with daily administration of necrosulfonamide (5 mg/kg body weight) or vehicle starting 3 days prior to angiotensin II infusion for 30 days. Necrosulfonamide treatment remarkably suppressed AAA enlargement, as indicated by reduced suprarenal maximal external diameter and surface area, and lowered the incidence and reduced the severity of experimental AAAs. Histologically, necrosulfonamide treatment attenuated medial elastin breaks, smooth muscle cell depletion, and aortic wall collagen deposition. Macrophages, CD4+ T cells, CD8+ T cells, and neovessels were reduced in the aneurysmal aortas of necrosulfonamide- as compared to vehicle-treated angiotensin II-infused mice. Atherosclerosis and intimal macrophages were also substantially reduced in suprarenal aortas from angiotensin II-infused mice following necrosulfonamide treatment. Additionally, the levels of serum interleukin-1β and interleukin-18 were significantly lower in necrosulfonamide- than in vehicle-treated mice without affecting body weight gain, lipid levels, or blood pressure. Our findings indicate that necrosulfonamide reduced experimental AAAs by preserving aortic structural integrity as well as reducing mural leukocyte accumulation, neovessel formation, and systemic levels of interleukin-1β and interleukin-18. Thus, pharmacologically inhibiting gasdermin D activity may lead to the establishment of nonsurgical therapies for clinical AAA disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin IIAortic Aneurysm, AbdominalSulfonamidesApolipoproteins EAnimalsMiceMalePhosphate-Binding ProteinsDisease Models, AnimalMice, Inbred C57BLMacrophagesIndolesMice, Knockout, ApoEGasdermins

Stichwörter der Autor:innen

abdominal aortic aneurysmsgasdermin Dnecrosulfonamide

Substanzen

Angiotensin IISulfonamidesApolipoproteins EPhosphate-Binding ProteinsGsdmd protein, mouseIndolesGasdermins

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, First Hospital Shanxi Medical University, Taiyuan 030001, Shanxi, China.
  • Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Department of Pharmacology, School of Basic Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China.
  • Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.
  • Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.

ORCID-Profile: Wenjia Ai, Baohui Xu

Förderung

  • National Natural Science Foundation of China
  • Abroad Return Scholar Fund of Shanxi Province
  • Central Funds Guiding the Local Science and Technology Development

Zitieren

APA

Guo, J., Zhang, Q., Li, Z., Qin, M., Shi, J., Wang, Y., Ai, W., Ju, J., Samura, M., Tsao, P. S., & Xu, B. (2024). Gasdermin D Inhibitor Necrosulfonamide Alleviates Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. Biomolecules. https://doi.org/10.3390/biom14060726

Vancouver

Guo J, Zhang Q, Li Z, Qin M, Shi J, Wang Y, et al. Gasdermin D Inhibitor Necrosulfonamide Alleviates Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. Biomolecules. 2024. doi:10.3390/biom14060726

BibTeX
@article{Guo2024,
  author = {Guo, Jia and Zhang, Qing and Li, Zhidong and Qin, Min and Shi, Jinyun and Wang, Yan and Ai, Wenjia and Ju, Junjie and Samura, Makoto and Tsao, Philip S and Xu, Baohui},
  title = {Gasdermin D Inhibitor Necrosulfonamide Alleviates Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14060726}
}
Kostenlos starten →